BlackRock’s Aimmune Therapeutics, Inc. AIMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-3,734,188
| Closed | -$129M | – | 5143 |
|
|
2020
Q3 | $129M | Sell |
3,734,188
-191,932
| -5% | -$6.61M | ﹤0.01% | 1705 |
|
|
2020
Q2 | $65.6M | Buy |
3,926,120
+296,166
| +8% | +$4.95M | ﹤0.01% | 2077 |
|
|
2020
Q1 | $52.3M | Sell |
3,629,954
-46,941
| -1% | -$677K | ﹤0.01% | 2003 |
|
|
2019
Q4 | $123M | Buy |
3,676,895
+54,338
| +1% | +$1.82M | ﹤0.01% | 1835 |
|
|
2019
Q3 | $75.9M | Buy |
3,622,557
+79,402
| +2% | +$1.66M | ﹤0.01% | 2041 |
|
|
2019
Q2 | $73.8M | Sell |
3,543,155
-167,221
| -5% | -$3.48M | ﹤0.01% | 2089 |
|
|
2019
Q1 | $82.9M | Sell |
3,710,376
-12,735
| -0.3% | -$285K | ﹤0.01% | 1978 |
|
|
2018
Q4 | $89.1M | Sell |
3,723,111
-259,469
| -7% | -$6.21M | ﹤0.01% | 1873 |
|
|
2018
Q3 | $109M | Buy |
3,982,580
+338,740
| +9% | +$9.24M | ﹤0.01% | 1907 |
|
|
2018
Q2 | $98M | Buy |
3,643,840
+565,410
| +18% | +$15.2M | ﹤0.01% | 1939 |
|
|
2018
Q1 | $98M | Buy |
3,078,430
+334,618
| +12% | +$10.7M | ﹤0.01% | 1858 |
|
|
2017
Q4 | $104M | Sell |
2,743,812
-28,196
| -1% | -$1.07M | ﹤0.01% | 1846 |
|
|
2017
Q3 | $68.7M | Buy |
2,772,008
+158,400
| +6% | +$3.93M | ﹤0.01% | 2068 |
|
|
2017
Q2 | $53.7M | Buy |
2,613,608
+471,719
| +22% | +$9.7M | ﹤0.01% | 2194 |
|
|
2017
Q1 | $46.5M | Buy |
2,141,889
+2,139,355
| +84,426% | +$46.5M | ﹤0.01% | 2258 |
|
|
2016
Q4 | $52K | Sell |
2,534
-115
| -4% | -$2.36K | ﹤0.01% | 2856 |
|
|
2016
Q3 | $40K | Buy |
2,649
+1,695
| +178% | +$25.6K | ﹤0.01% | 3015 |
|
|
2016
Q2 | $10K | Buy |
954
+494
| +107% | +$5.18K | ﹤0.01% | 3376 |
|
|
2016
Q1 | $6K | Buy |
+460
| New | +$6K | ﹤0.01% | 3298 |
|